T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alcon
ALC
|
+$2.11B |
| 2 |
Linde
LIN
|
+$1.34B |
| 3 |
American International
AIG
|
+$1.34B |
| 4 |
Marvell Technology
MRVL
|
+$1.28B |
| 5 |
TSS
Total System Services, Inc.
TSS
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$2.27B |
| 2 |
Eli Lilly
LLY
|
+$1.64B |
| 3 |
NVIDIA
NVDA
|
+$1.59B |
| 4 |
RHT
Red Hat Inc
RHT
|
+$1.55B |
| 5 |
Booking.com
BKNG
|
+$1.12B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.88% |
| 2 | Healthcare | 16.96% |
| 3 | Financials | 13.79% |
| 4 | Consumer Discretionary | 13.57% |
| 5 | Industrials | 9.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BFS
776
Saul Centers
BFS
$850M
| $66.8M | 0.01% |
1,189,920
+38,367
| +3% | +$2.09M |
|
777
Ryanair
RYAAY
$30.8B
| $66.6M | 0.01% |
2,594,215
+33,290
| +1% | +$943K |
|
778
Kraft Heinz
KHC
$29.1B
| $66.5M | 0.01% |
2,142,732
+997,963
| +87% | +$31.5M |
|
|
BERY
779
DELISTED
Berry Global Group, Inc.
BERY
| $66.4M | 0.01% |
1,375,363
-12,172
| -0.9% | -$586K |
|
780
Allstate
ALL
$64.7B
| $66.2M | 0.01% |
650,568
-27
| -0% | -$2.64K |
|
781
Mesa Laboratories
MLAB
$631M
| $66M | 0.01% |
270,249
-12,060
| -4% | -$2.81M |
|
782
Independent Bank
INDB
$4.04B
| $65.9M | 0.01% |
865,621
+847,010
| +4,551% | +$66M |
|
|
BECN
783
DELISTED
Beacon Roofing Supply, Inc.
BECN
| $65.9M | 0.01% |
1,794,506
+229,434
| +15% | +$8.31M |
|
784
Wintrust Financial
WTFC
$11B
| $65.7M | 0.01% |
898,579
-35,824
| -4% | -$2.62M |
|
|
TRHC
785
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $65.7M | 0.01% |
1,315,216
+202,683
| +18% | +$10.1M |
|
786
Dorman Products
DORM
$3.97B
| $65.6M | 0.01% |
753,370
-11,231
| -1% | -$976K |
|
787
Pebblebrook Hotel Trust
PEB
$2.04B
| $65.6M | 0.01% |
2,328,087
-355,827
| -13% | -$10.8M |
|
788
Hexcel
HXL
$7.74B
| $65.5M | 0.01% |
810,248
-44,416
| -5% | -$3.23M |
|
789
Helen of Troy
HELE
$696M
| $65.2M | 0.01% |
499,386
-3,120
| -0.6% | -$408K |
|
790
Fortinet
FTNT
$118B
| $65M | 0.01% |
4,229,695
+97,565
| +2% | +$1.61M |
|
791
Champion Homes
SKY
$5.1B
| $64.9M | 0.01% |
2,372,011
+54,847
| +2% | +$1.25M |
|
|
LOMA
792
Loma Negra
LOMA
$1.13B
| $64.9M | 0.01% |
5,550,406
-151,910
| -3% | -$1.6M |
|
|
CVET
793
DELISTED
Covetrus, Inc. Common Stock
CVET
| $63.7M | 0.01% |
2,604,165
+448,804
| +21% | +$12.9M |
|
794
Paychex
PAYX
$42.8B
| $63.7M | 0.01% |
773,882
-4,255
| -0.5% | -$359K |
|
795
Williams Companies
WMB
$90.1B
| $63.6M | 0.01% |
2,267,270
+12,603
| +0.6% | +$350K |
|
|
AZPN
796
DELISTED
ASPEN TECHNOLOGY INC
AZPN
| $63.4M | 0.01% |
509,877
-216,545
| -30% | -$26.9M |
|
|
PRA
797
DELISTED
ProAssurance
PRA
| $63.1M | 0.01% |
1,748,123
+45,280
| +3% | +$1.68M |
|
798
CTS Corp
CTS
$1.82B
| $63.1M | 0.01% |
2,286,150
+385,708
| +20% | +$11.1M |
|
799
Lantheus
LNTH
$6.57B
| $63M | 0.01% |
2,225,763
+390,644
| +21% | +$9.92M |
|
800
Exponent
EXPO
$3.22B
| $62.4M | 0.01% |
1,065,735
-7,884
| -0.7% | -$449K |
|
Similar funds
T. Rowe Price Associates's Q2 2019 Portfolio in Review
As of Q2 2019, T. Rowe Price Associates held 2,600 positions worth $712B, up 4.7% from $680B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
T. Rowe Price Associates's Q2 2019 filing shows 72 new, 1,394 increased, 949 reduced and 59 closed positions. Its largest new stake was Alcon: 36,020,796 shares worth $2.23B. The largest sale was UnitedHealth, an estimated $2.27B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2019 buy was Alcon: 36,020,796 shares worth $2.23B.
- T. Rowe Price Associates added most to Linde in Q2 2019, an estimated $1.34B increase.
- T. Rowe Price Associates's biggest Q2 2019 reduction was UnitedHealth, cutting an estimated $2.27B.
- T. Rowe Price Associates fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $609M.
- T. Rowe Price Associates's ten largest holdings make up 21% of its $712B portfolio in Q2 2019.
- T. Rowe Price Associates opened 72 new positions and closed 59 in Q2 2019.
- T. Rowe Price Associates's portfolio value rose 4.7% quarter-over-quarter to $712B.
Based on T. Rowe Price Associates's 13F filing for Q2 2019, filed 15 Aug 2019.